Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3. This appears to be a minor site maintenance update with no changes to study details or visible features.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedRevision updated to v3.4.2. The prior funding-status notice and revision v3.4.1 were removed.SummaryDifference0.4%

- Check41 days agoChange DetectedA site-wide notice about government funding and NIH Clinical Center operating status has been added, with links to cc.nih.gov and opm.gov. A revision note updated the site version from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check48 days agoChange DetectedGlossary toggle added to the page. Footer metadata updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and revision 'v3.4.0'; the previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and revision 'v3.3.4' were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision tag updated to v3.3.4, replacing v3.3.3; no changes to the study details, eligibility criteria, or outcomes.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a Locations section with a California site for the study; page revision updated to v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.